Michael Robert Kinzinger, MD
Otolaryngology · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 6
Offices
6 locations · Sutter Bay Medical Foundation · County of San Mateo
Hospitals listed: Mills-Peninsula Medical Center · San Mateo Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kinzinger’s office to ask if they take your plan before you enroll.
State licence records
1 licence
- Washington MD.MD.60934004Physician And Surgeon License · since 2019 · expires 2021-11-17ExpiredNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- San Mateo Medical CenterSan Mateo, CAAcute Care Hospital · Government - Local · Has an emergency departmentPart of San Mateo County HealthPatients rate it 3 of 5 · 68% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for San Mateo Medical Center
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.34 (0.25 to 2.43) · 45 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.97 (0.48 to 1.47) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 25 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 258 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 379 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 381 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.44 (0.82 to 6.05) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.64 (0.92 to 4.37) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.53 (0 to 1.76) · 296 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.661 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 47 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.3 · 25 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.4 to 18.9) · 167 cases | No different | Jan 2022 – Dec 2024 |
What patients said (208 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$163,225
Medicare paid this office $163,225 for 643 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 247 | $23,711 | $64 |
| Diagnostic exam of voice box using a flexible endoscope | 165 | $17,871 | $92 |
| New patient visit (45+ min) | 137 | $15,784 | $115 |
| New patient visit (30+ min) | 199 | $14,623 | $73 |
| Diagnostic exam of nasal passages using an endoscope | 77 | $13,256 | $135 |
See all 13 services
| Short return visit (20+ min) | 247 | $23,711 | $64 |
| Diagnostic exam of voice box using a flexible endoscope | 165 | $17,871 | $92 |
| New patient visit (45+ min) | 137 | $15,784 | $115 |
| New patient visit (30+ min) | 199 | $14,623 | $73 |
| Diagnostic exam of nasal passages using an endoscope | 77 | $13,256 | $135 |
| Return visit (30+ min) | 113 | $12,194 | $90 |
| Ct scan of face without contrast | 33 | $3,719 | $101 |
| Professional service for preparation and provision of 1 or more antigens | 13 | $3,359 | $11 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,383 | $95 |
| Removal of impacted ear wax | 37 | $1,228 | $31 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 25 | $919 | $37 |
| Exam of ear using a microscope | 24 | $631 | $20 |
| Professional service for multiple injections of allergen | 46 | $545 | $9 |
Procedures Medicare counted
| Skin biopsy | 1-10 | None |
Who their Medicare patients are
643 Original Medicare patients in 2024. Average age 75 · Under 65 3% · 85 and older 11% · Women 58% · Also on Medicaid 5% · Health risk score 1.15. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 67% · Coronary heart disease 29% · Chronic kidney disease 24% · Diabetes 19% · Depression 19% · Cancer 18% · Atrial fibrillation 18% · COPD 14% · Heart failure 13% · Stroke 8% · Dementia 4%.
The office billed $476,021, Medicare allowed $217,110 and paid $163,225; for 1,971 services of 80 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 643 | 1,971 | 75 | 1.15 | $476,021 | $163,225 |
| 2023 | 571 | 1,827 | 74 | 1.06 | $365,231 | $109,852 |
| 2022 | 540 | 1,513 | 74 | 1.10 | $363,374 | $114,933 |
| 2021 | 299 | 1,025 | 75 | 1.16 | $167,332 | $92,887 |
| 2020 | 79 | 212 | 76 | 1.29 | $28,464 | $18,911 |
| 2019 | 24 | 27 | 67 | 1.73 | $5,901 | $2,017 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 11 services
| New patient visit (30+ min) | 262 | $17,475 | $67 |
| Diagnostic exam of voice box using a flexible endoscope | 135 | $12,617 | $85 |
| Short return visit (20+ min) | 149 | $12,047 | $59 |
| New patient visit (45+ min) | 97 | $10,041 | $104 |
| Diagnostic exam of nasal passages using an endoscope | 48 | $7,011 | $130 |
| Return visit (30+ min) | 51 | $5,304 | $84 |
| Professional service for preparation and provision of 1 or more antigens | 11 | $2,730 | $11 |
| Removal of impacted ear wax | 28 | $1,053 | $31 |
| Professional service for multiple injections of allergen | 66 | $1,036 | $8 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $914 | $76 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 25 | $794 | $32 |
2022: 12 services
| New patient visit (30+ min) | 284 | $21,365 | $75 |
| Short return visit (20+ min) | 201 | $17,494 | $65 |
| Diagnostic exam of voice box using a flexible endoscope | 107 | $11,361 | $99 |
| Diagnostic exam of nasal passages using an endoscope | 57 | $8,813 | $144 |
| New patient visit (45+ min) | 73 | $8,193 | $112 |
| Return visit (30+ min) | 23 | $2,097 | $87 |
| Removal of impacted ear wax | 51 | $1,565 | $30 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,155 | $105 |
| Comprehensive hearing and speech recognition test | 35 | $1,077 | $27 |
| Test for eardrum and muscle function | 29 | $582 | $17 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 15 | $579 | $39 |
| Professional service for multiple injections of allergen | 33 | $354 | $9 |
2021: 14 services
| Short return visit (20+ min) | 161 | $20,261 | $77 |
| New patient visit (45+ min) | 112 | $15,262 | $136 |
| New patient visit (30+ min) | 92 | $8,550 | $93 |
| Return visit (30+ min) | 34 | $4,307 | $113 |
| Diagnostic exam of voice box using a flexible endoscope | 29 | $3,549 | $114 |
| Comprehensive hearing and speech recognition test | 93 | $3,226 | $33 |
| Diagnostic exam of nasal passages using an endoscope | 16 | $3,058 | $180 |
| Long return visit (40+ min) | 17 | $2,663 | $148 |
| Removal of impacted ear wax | 50 | $2,119 | $40 |
| Test for eardrum and muscle function | 91 | $1,853 | $19 |
| Ultrasound scan of head and neck soft tissue | 16 | $1,754 | $110 |
| Evaluation and testing for balance with recording | 13 | $1,292 | $99 |
| Test to assess balance during warm and cool irrigation in both ears | 12 | $452 | $38 |
| Use of electrodes during balance testing | 12 | $114 | $10 |
2020: 4 services
| Short return visit (20+ min) | 34 | $3,371 | $64 |
| New patient visit (45+ min) | 23 | $3,335 | $145 |
| New patient visit (30+ min) | 27 | $2,345 | $87 |
| Diagnostic exam of voice box using a flexible endoscope | 14 | $1,588 | $113 |
Medicaid work
$42,372 in 2024
Medicaid paid $42,372 for 600 billed services this clinician did in 2024, up to 27 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| New patient visit (30+ min) | 194 | $13,384 |
| Short return visit (20+ min) | 150 | $7,276 |
| New patient visit (45+ min) | 76 | $7,209 |
| Diagnostic flexible fiberoptic laryngoscopy | 57 | $6,205 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 26 | $4,709 |
| Return visit (30+ min) | 26 | $1,957 |
| Comprehensive audiometry threshold evaluation and speech recognition | 29 | $999 |
| TYMPANOMETRY | 42 | $632 |
| 2024 | 600 | 8 | 27 | $42,372 |
| 2023 | 600 | 8 | 35 | $38,543 |
| 2022 | 363 | 6 | 33 | $19,882 |
See the largest Medicaid services in earlier years
2023
| New patient visit (30+ min) | 259 | $16,102 |
| Diagnostic flexible fiberoptic laryngoscopy | 83 | $8,177 |
| Short return visit (20+ min) | 102 | $5,553 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 33 | $3,578 |
| Nasal endoscopy, diagnostic, unilateral or bilateral (separate procedure) | 13 | $2,235 |
| TYMPANOMETRY | 72 | $1,095 |
| New patient visit (45+ min) | 13 | $985 |
| Comprehensive audiometry threshold evaluation and speech recognition | 25 | $818 |
2022
| New patient visit (30+ min) | 195 | $11,454 |
| Short return visit (20+ min) | 80 | $3,550 |
| Diagnostic flexible fiberoptic laryngoscopy | 45 | $3,345 |
| New patient visit (45+ min) | 13 | $1,079 |
| Comprehensive audiometry threshold evaluation and speech recognition | 13 | $287 |
| TYMPANOMETRY | 17 | $167 |
Drugs they prescribed that Part D paid
$14,238
Pharmacies billed $14,238 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 9% of their Part D prescriptions (68 of 748) in 2024. Above the middle of the specialty; the typical otolaryngology clinician is at 4%.
724 generic and 24 brand-name prescriptions · $14,238 in drug cost · 105 antibiotic prescriptions to 65 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Azelastine | 123 | $3,123 | $25 |
| Ipratropium | 65 | $1,636 | $25 |
| Budesonide | 12 | $1,488 | $124 |
| Fluticasone Propionate | 94 | $1,365 | $15 |
| Amoxicillin-Clavulanate Potass | 47 | $946 | $20 |
See all 18 drugs
| Azelastine | 123 | $3,123 | $25 |
| Ipratropium | 65 | $1,636 | $25 |
| Budesonide | 12 | $1,488 | $124 |
| Fluticasone Propionate | 94 | $1,365 | $15 |
| Amoxicillin-Clavulanate Potass | 47 | $946 | $20 |
| Pilocarpine | 17 | $482 | $28 |
| Ofloxacin | 19 | $481 | $25 |
| Triamcinolone Acetonide | 16 | $478 | $30 |
| Prednisolone Acetate | 11 | $470 | $43 |
| Hydrocodone-Acetaminophen | 50 | $371 | $7 |
| Doxycycline Hyclate | 16 | $366 | $23 |
| Omeprazole | 29 | $274 | $9 |
| Clindamycin | 23 | $259 | $11 |
| Prednisone | 45 | $235 | $5 |
| Mupirocin | 24 | $151 | $6 |
| Montelukast | 22 | $130 | $6 |
| Methylprednisolone | 13 | $117 | $9 |
| Levothyroxine | 16 | $101 | $6 |
Year by year
| 2024 | 748 | 290 | 9% (68) | 3% | $14,238 |
| 2023 | 582 | 243 | 9% (52) | 2% | $14,063 |
| 2022 | 450 | 236 | 6% (27) | 4% | $13,334 |
| 2021 | 277 | 140 | None | 8% | $7,806 |
| 2020 | 60 | 32 | None | None | $2,326 |
| 2019 | 46 | 31 | None | None | $922 |
| 2018 | 104 | 62 | 22% (23) | 12% | $1,884 |
| 2017 | 87 | 54 | 39% (34) | None | $2,414 |
| 2016 | 66 | 43 | 52% (34) | 17% | $5,691 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 15 drugs
| Azelastine | 105 | $3,004 | $29 |
| Ipratropium | 46 | $1,873 | $41 |
| Fluticasone Propionate | 84 | $1,174 | $14 |
| Prednisone | 41 | $1,024 | $25 |
| Amoxicillin-Clavulanate Potass | 47 | $656 | $14 |
| Triamcinolone Acetonide | 17 | $479 | $28 |
| Ofloxacin | 13 | $270 | $21 |
| Hydrocodone-Acetaminophen | 28 | $250 | $9 |
| Clindamycin | 17 | $236 | $14 |
| Montelukast | 20 | $155 | $8 |
| Omeprazole | 16 | $138 | $9 |
| Famotidine | 11 | $95 | $9 |
| Mupirocin | 14 | $91 | $7 |
| Oxycodone-Acetaminophen | 12 | $79 | $7 |
| Methylprednisolone | 12 | $70 | $6 |
2022: 11 drugs
| Ipratropium | 59 | $2,489 | $42 |
| Azelastine | 59 | $1,873 | $32 |
| Ofloxacin | 18 | $1,233 | $69 |
| Fluticasone Propionate | 67 | $979 | $15 |
| Prednisone | 33 | $894 | $27 |
| Amoxicillin-Clavulanate Potass | 39 | $733 | $19 |
| Omeprazole | 32 | $360 | $11 |
| Clindamycin | 15 | $359 | $24 |
| Hydrocodone-Acetaminophen | 20 | $174 | $9 |
| Mupirocin | 12 | $134 | $11 |
| Famotidine | 12 | $81 | $7 |
2021: 8 drugs
| Ipratropium | 47 | $1,626 | $35 |
| Ofloxacin | 18 | $1,269 | $71 |
| Prednisolone Acetate | 18 | $878 | $49 |
| Amoxicillin-Clavulanate Potass | 30 | $547 | $18 |
| Azelastine | 13 | $502 | $39 |
| Clindamycin | 20 | $289 | $14 |
| Fluticasone Propionate | 17 | $253 | $15 |
| Prednisone | 17 | $83 | $5 |
2018: 1 drug
| Hydrocodone-Acetaminophen | 18 | $102 | $6 |
2017: 1 drug
| Hydrocodone-Acetaminophen | 30 | $363 | $12 |
2016: 1 drug
| Hydrocodone-Acetaminophen | 22 | $889 | $40 |
Money from drug and device companies
$68 in 2025
| 2025 | 2 | 3 | None | $68 |
| 2024 | 7 | 15 | None | $476 |
| 2023 | 5 | 10 | None | $497 |
| 2022 | 6 | 11 | None | $614 |
| 2021 | 6 | 8 | None | $195 |
| 2020 | 2 | 3 | None | $43 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Aerin Medical | Vivaer Stylus | $53 | 2 payments
|
| Genzyme | Dupixent | $15 | 1 payment
|
See all 3 published payments
| Aerin Medical | Meals · 2025-10-02 | Vivaer Stylus | $28 |
| Aerin Medical | Meals · 2025-02-07 | Vivaer Stylus | $25 |
| Genzyme | Meals · 2025-01-22 | Dupixent | $15 |
See earlier years (2024, 2023, 2022, 2021, 2020)
2024: $476
| Medtronic | Stealthstation S8 Platform | $178 | 4 payments
|
| Aerin Medical | Vivaer Stylus | $93 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $62 | 2 payments
|
| Genzyme | Dupixent | $57 | 2 payments
|
| Stryker | Audion Et Dilation System | $53 | 1 payment
|
| KLS-Martin L.P. | None | $21 | 1 payment
|
| Itamar Medical | Watchpatone | $12 | 1 payment
|
2023: $497
| Aerin Medical | Vivaer Stylus | $163 | 5 payments
|
| Stryker | Scopis Ent | $140 | 1 payment
|
| KLS-Martin L.P. | None | $133 | 1 payment
|
| GlaxoSmithKline | Nucala | $38 | 2 payments
|
| Genzyme | Dupixent | $22 | 1 payment
|
2022: $614
| Stryker | Latera | $334 | 5 payments
|
| DePuy Synthes Sales | Trumatch | $149 | 1 payment
|
| GlaxoSmithKline | Nucala | $63 | 2 payments
|
| Genzyme | Dupixent | $32 | 1 payment
|
| OptiNose US | Xhance | $19 | 1 payment
|
| Tactile Systems Technology | Flexitouch Plus | $17 | 1 payment
|
2021: $195
| Stryker | Fiagon Navigation Unit | $67 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $58 | 3 payments
|
| GlaxoSmithKline | Nucala | $31 | 1 payment
|
| Intersect ENT | Propel | $14 | 1 payment
|
| Genzyme | Dupixent | $14 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $12 | 1 payment
|
2020: $43
| Tactile Systems Technology | Flexitouch | $27 | 2 payments
|
| Acclarent | Acclarent Navwire Sinus Navigation Guidewire | $16 | 1 payment
|
Professional record
- NPI
- 1124434071
- Licence
- WA MD60934004Washington MD.MD.60934004: Expired
- Group
- Sutter Bay Medical Foundation · County of San Mateo
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- WA 1124434071
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2014-07-10
- NPI last updated
- 2026-09-03
- NPI record certified
- 2026-09-03
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 2240 N Harbor Blvd Ste 200, Fullerton, CA, 92835 · 1959 Ne Pacific St, Seattle, WA, 98195 · 2121 N Craycroft Rd Bldg 5, Tucson, AZ, 85712